The cure rate was higher in the telavancin than the vancomycin treatment group in microbiologically evaluable patients with only Gram-positive pathogens isolated at baseline [ 85.0 % ( 130/153 ) versus 75.2 % ( 109/145 ) , respectively ; treatment difference ( 95 % CI ) : 9.7 % ( 0.6 % -18.8 % ) ] .